Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$2.95 - $4.38 $51,330 - $76,212
-17,400 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$3.99 - $19.33 $23,142 - $112,113
-5,800 Reduced 25.0%
17,400 $70,000
Q4 2018

Feb 11, 2019

SELL
$16.15 - $28.93 $230,944 - $413,699
-14,300 Reduced 38.13%
23,200 $384,000
Q3 2018

Nov 14, 2018

BUY
$20.21 - $31.85 $757,875 - $1.19 Million
37,500 New
37,500 $1.09 Million

About Aptinyx Inc.


  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.